Investors

|

Portal
Order

Caris Detect™ Multi-Cancer Early Detection Test Now Available.

Learn More
Home / Research

Innovation

Research

Meeting the Demands of the Molecular Age

Caris Life Sciences is a pioneer in precision medicine, innovating real-world solutions to meet the demands of the molecular age. Since the beginning, Caris has taken on healthcare’s biggest challenges, seeking to provide the most comprehensive molecular insights for every patient and reduce the burden of disease. A convergence of rapid advances in next-generation sequencing, machine learning, artificial intelligence and computing power has driven Caris research, collaborations and inventions.

Order Testing
Physician Services

Product Pipeline

Improving Outcomes with Blood-Based Cancer Detection

Multi-Cancer Early Detection (MCED) is a type of blood test that can screen for many types of cancer to measure molecular markers circulating in the blood to identify the presence of cancer at its earliest stages. The goal for Caris’ application of MCED is to catch cancer earlier – before the tumor can spread to other parts of the body – and help improve the chance for a more successful outcome.

What is Molecular Artificial Intelligence?

The precision medicine era has arrived, and molecular profiling has become standard of care for many cancer types. Machine learning and artificial intelligence tools are critical in helping physicians navigate these data-dense resources to make the best decision for each patient.

Learn More

Research and Precision Medicine Tools

As a pioneer in precision medicine, Caris has a longstanding commitment to advance precision medicine through innovative research and novel solutions to improve the human condition.

Publications

Every day, new discoveries confirm the increasing and important role biomarker analysis and tumor profiling have in personalized cancer care. We contribute to oncology research to advance the understanding of molecular science, explore ways to improve patient care, enhance the healthcare delivery system and transform precision medicine into reality.

Nanoverse

Through the power of AI and vast amounts of molecular data, Caris has developed a revolutionary mechanism to unravel the biological complexity of diseases. The Caris Nanoverse™ provides physicians and researchers a new way to identify patient populations, predict therapy responses and identify targets for drug development in ways never before possible.

Caris CODEai

Caris CODEai™ is state-of-the-art informatics system and big data architecture that provides an unmatched resource for developing a better understanding of the molecular mechanisms of cancer and helps researchers and biopharma companies derive unique insights to support commercial and product development objectives, clinical trial services, target identification and research initiatives.

Tour Our R&D Lab

Caris is committed to leveraging advanced technologies and conducting innovative research in advancing cancer care and pioneering the next generation of precision medicine. Check out our R&D laboratory in Tempe, Arizona.

Discover
More

Publications

Our commitment to advancing cancer care and molecular research spans more than a decade. We explore ways to improve patient care, enhance the healthcare delivery system and transform precision medicine into reality.

Artificial Intelligence

With one of the largest, multi-modal databases of combined molecular and clinical outcomes data in the world, Caris applies highly sophisticated AI bioinformatics and machine learning capabilities on this massive database to create novel, clinically relevant solutions to classify cancer at the molecular level and predict patient response in ways never before possible.

Contact Us

Ready to Get Started on the Journey?